Skip to content
Screener

GeneDx Holdings WGS Other revenue — Total Revenue

Similar metrics at other companies

ImmunityBio, Inc. logo
IBRXOther revenues — Total Revenue
$39K+388%
Life Time Group Holdings logo
LTHOther revenue — Total Revenue
$28.59M+11.7%
Sirius XM logo
SIRIOther revenue — Total Revenue
$68M-11.7%
Moderna logo
MRNAOther revenue — Total Revenue
$37M+68.2%
Snap logo
SNAPOther revenue — Total Revenue
$316.47M+84.7%
8x8, Inc. logo
EGHTOther revenue — Total Revenue
$4.82M-4.5%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.08B-31.7%
Enterprise value$2.08B-31.2%
P/S4.7×-3.7×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemThree months ended March 31, 20262025
Revenue
Diagnostic test revenue$101,299$85,759
Other revenue9551,356
Total revenue102,25487,115
Cost of services34,04328,639
Gross profit68,21158,476
Research and development19,80412,577
Selling, general and administrative74,59150,450

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's other revenue — total revenue?
GeneDx Holdings (WGS) reported other revenue — total revenue of $955K in Q1 2026.
How has GeneDx Holdings's other revenue — total revenue changed year-over-year?
GeneDx Holdings's other revenue — total revenue decreased by 29.6% year-over-year, from $1.36M to $955K.
What is the long-term trend for GeneDx Holdings's other revenue — total revenue?
Over 4 years (2021 to 2025), GeneDx Holdings's other revenue — total revenue has grown at a 12.0% compound annual growth rate (CAGR), from $7.1M to $11.15M.
What does other revenue — total revenue mean?
This metric represents the total gross revenue generated from business activities classified under the 'Other' segment, which typically includes ancillary services or non-core product lines. It serves as an indicator of the company's ability to diversify its income streams beyond primary operations. Monitoring this figure helps investors assess the contribution of secondary business units to the overall top-line financial performance.

Ask your AI about GeneDx Holdings's other revenue — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude